Scibase Holding AB (5J3)

Overview

SciBase Holding AB (publ) stands out as an innovator in the medical technology sector, focusing on the development and commercialization of advanced point-of-care platforms leveraging electrical impedance spectroscopy. This sophisticated technology is primarily utilized for the detailed evaluation of various skin disorders. The company’s operations span across a global network, including Europe, the United States, North America, Asia, Oceania, and other international markets. Structured into two primary segments, Skin Cancer and Skin Barrier Assessment, SciBase Holding AB has made significant inroads in the early detection and assessment of skin-related health issues. With its foundations laid in 1998, the company boasts a seasoned history of industry expertise and is strategically headquartered in Sundbyberg, Sweden, aligning well with its global operational framework.

Products and Services

SciBase Holding AB (publ)’s portfolio of innovative solutions is designed to meet the critical needs of skin disorder evaluations. Each product is developed with precision, ensuring that healthcare professionals can offer accurate diagnostics and assessments. The company's key offerings include:

• Nevisense: This state-of-the-art point-of-care platform is adept at detecting melanoma and non-melanoma skin cancer with a high degree of accuracy. Through the non-invasive method of electrical impedance spectroscopy, Nevisense enables the early detection of skin cancers, facilitating timely intervention and treatment strategies.
• Nevisense Go: Continuing the legacy of its predecessor, Nevisense Go serves as an enhanced, portable version, offering the same accurate detection capabilities for melanoma and non-melanoma skin cancers. Its compact design and ease of use make it an ideal solution for clinics and healthcare facilities, promoting widespread access to critical diagnostic processes.
• Skin Barrier and Inflammation Assessment: Beyond cancer detection, SciBase’s platforms extend to the assessment of the skin barrier and inflammation. This application of electrical impedance spectroscopy aids in diagnosing various skin conditions and disorders by evaluating the skin's integrity and inflammatory responses. By providing critical insights into the skin's health, these assessments assist in tailoring personalized treatment and management plans.